Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 8-K Event Other events
  4. 4/A Returned to the company President - Asia Pacific returned 13,366 shares (to the company)
  5. 5 Insider Annual Insider Trading Report
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Returned to the company President - Asia Pacific returned 13,366 shares (to the company)
  8. 4 Returned to the company Chief Financial Officer returned 14,070 shares (to the company)
  9. 4 Returned to the company President returned 15,477 shares (to the company)
  10. 4 Returned to the company Chief Executive Officer returned 21,105 shares (to the company)
  11. 4 Grant or award Director acquired 6,100 shares (grant or award)
  12. 4 Grant or award Director acquired 6,100 shares (grant or award)
  13. 4 Grant or award Director acquired 6,100 shares (grant or award)
  14. 4 Grant or award Director acquired 6,100 shares (grant or award)
  15. 4 Grant or award Director acquired 6,100 shares (grant or award)
  16. 4 Grant or award Director acquired 6,100 shares (grant or award)
  17. 4/A Open-market buy President bought 10,000 shares at $2.85 ($28,500)
  18. 4 Open-market buy President bought 10,000 shares at $2.85 ($28,500)
  19. 4 Open-market buy Director bought 32,000 shares at $2.85 ($91,200)
  20. 4 Open-market buy Director bought 25,000 shares at $2.85 ($71,250)

Page 46 of 74 · 1,465 filings